Home > Boards > US Listed > Biotechs > Cyclacel Pharmaceutical, Inc. (CYCC)

added some 1.52's fri.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
rivervalley Member Profile
 
Followed By 53
Posts 5,257
Boards Moderated 0
Alias Born 05/24/11
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2020 5:18:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2020 8:48:44 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2020 8:47:01 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/12/2020 8:46:08 AM
Cyclacel Pharmaceuticals Reports Third Quarter 2020 Financial Results GlobeNewswire Inc. - 11/11/2020 4:05:00 PM
Cyclacel Pharmaceuticals to Release Third Quarter Financial Results GlobeNewswire Inc. - 11/5/2020 9:29:12 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/29/2020 4:07:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2020 4:13:36 PM
Cyclacel Presents Phase 1 Clinical Data Showing Safety, Anti-Tumor Activity and Good Oral Bioavailability of Fadraciclib in P... GlobeNewswire Inc. - 10/26/2020 8:26:28 AM
Cyclacel Pharmaceuticals Announces Appointment of Mark Kirschbaum, M.D., as Chief Medical Officer GlobeNewswire Inc. - 10/23/2020 4:30:10 PM
Cyclacel Pharmaceuticals to Present at the October 2020 Lytham Partners Virtual Investor Growth Conference GlobeNewswire Inc. - 10/5/2020 7:00:10 AM
Cyclacel Announces Fadraciclib Abstract Selected for Oral Presentation in the Late Breaking and Best Proffered Paper Session ... GlobeNewswire Inc. - 9/21/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/2/2020 5:05:22 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2020 5:17:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/12/2020 4:17:07 PM
Cyclacel Pharmaceuticals Reports Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/12/2020 4:05:10 PM
Cyclacel Pharmaceuticals to Release Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/5/2020 7:00:10 AM
Cyclacel’s Clinical Stage CDK2/9 Inhibitor Fadraciclib Targets Key Anti-Apoptotic and Oncogenic Pathways in Cancer GlobeNewswire Inc. - 7/13/2020 7:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2020 6:50:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2020 6:49:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2020 6:49:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/29/2020 4:02:36 PM
Cyclacel Pharmaceuticals Reports First Quarter 2020 Financial Results GlobeNewswire Inc. - 5/12/2020 4:05:10 PM
Cyclacel Pharmaceuticals to Release First Quarter 2020 Financial Results GlobeNewswire Inc. - 5/5/2020 7:00:10 AM
Cyclacel Announces Closing of $20 Million Public Offering GlobeNewswire Inc. - 4/24/2020 4:05:10 PM
rivervalley   Monday, 02/26/18 10:49:29 AM
Re: None
Post # of 2463 
added some 1.52's fri.

Posts are my opinion only and not to be considered as investment advice to others.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences